Who
Katey Einterz Owen
Director
Company insider
Files Form 4 as: Director, Adaptive Biotechnologies.
In numbers
- Trades disclosed
- 16
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $500K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 17 Mar 2021
- Last trade
- 31 Aug 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Aug 2026filed 2 Sep 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code G | —12,539 | filing |
| 31 Aug 2026filed 2 Sep 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code G | —12,539 | filing |
| 26 Aug 2026filed 28 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $250K9,615 at $26.00 | filing |
| 26 Aug 2026filed 28 Aug 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $250K9,615 at $26.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —15,625 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —15,625 at $0.00 | filing |
| 4 Mar 2025filed 6 Mar 2025 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —23,726 at $0.00 | filing |
| 4 Mar 2025filed 6 Mar 2025 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —15,394 at $0.00 | filing |
| 4 Mar 2024filed 6 Mar 2024 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —48,044 at $0.00 | filing |
| 4 Mar 2024filed 6 Mar 2024 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —31,328 at $0.00 | filing |
| 6 Mar 2023filed 8 Mar 2023 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —23,329 at $0.00 | filing |
| 6 Mar 2023filed 8 Mar 2023 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —14,775 at $0.00 | filing |
| 26 Jan 2022filed 28 Jan 2022 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,722 at $0.00 | filing |
| 26 Jan 2022filed 28 Jan 2022 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —6,689 at $0.00 | filing |
| 17 Mar 2021filed 22 Mar 2021 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —4,443 at $0.00 | filing |
| 17 Mar 2021filed 22 Mar 2021 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —11,109 at $0.00 | filing |
News
Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells 11,881 Shares of Company StockADPT · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name Katey Einterz Owen; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.